Sugen deal

Marion Merrell Dow Inc. completed the previously announced acquisition of Selectide (Tucson, Ariz.), developer of combinatorial chemistry and rapid screening technologies for pharmaceutical research (see BioCentury, Jan. 9). MMD paid $58 million plus $3 million to acquire the 5 percent stake in Selectide held by SUGN. ...